Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988753 · ClinicalTrials.gov registry record
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
A clinical trial of Hepatitis C and Hepatitis B, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT01988753 is a study of Hepatitis C and Hepatitis B that has completed, run by Baylor College of Medicine. The registered enrollment target is 17 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01988753, a study of Hepatitis C and Hepatitis B, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to develop new techniques for early diagnosis of liver disease. These techniques are: Shearwave Elastography (SWE) ultrasound and blood biomarkers. SWE ultrasound uses high-frequency sound waves to view soft tissues such as muscles and internal organs and measure stiffness. An ultrasound creates computer images that show internal body organs, such as the liver or kidneys, more clearly than regular x-ray images. Biomarkers are biological molecules found in the blood that provide important information about liver disease.
Conditions Studied
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-10 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01988753
The ClinicalTrials.gov registry entry for NCT01988753 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (99% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Hepatitis C appearing as the primary indexed condition, and to 0 interventions.
NCT01988753 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01988753 about?
NCT01988753 is a clinical study titled "Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases". This study is being conducted to develop new techniques for early diagnosis of liver disease. These techniques are: Shearwave Elastography (SWE) ultrasound and blood biomarkers. SWE ultrasound uses high-frequency sound waves to view soft tissues such as muscles and internal organs and measure stiff...
What is the current status of trial NCT01988753?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2013-10. Estimated completion is 2016-06.
What conditions does trial NCT01988753 study?
This clinical trial studies the following conditions: Hepatitis C, Hepatitis B, Liver Disease, Liver Fibrosis, Viral Hepatitis.
Who is sponsoring clinical trial NCT01988753?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01988753 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Evaluation of Patients With Liver Disease
RECRUITING
-
The HOPE Study: Characterizing Patients With Hepatitis B and C
RECRUITING
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.